The Graft Versus Tumor (GVT) effect is a phenomenon observed after a patient undergoes a hematopoietic stem cell transplant (HSCT). It involves the immune cells from the donor (the graft) attacking the cancer cells in the recipient (the tumor). This effect is particularly significant in the treatment of hematologic malignancies, such as leukemia, lymphoma, and multiple myeloma.
